To assess the clinical significance of sFRP1, we analyzed clinicopathological data in 26 patients with HCC and found that the expression of sFRP1 at both the mRNA and protein levels was remarkably higher in non-tumoral liver tissues than that in HCC tissues (Fig. 5c, d). This evidence concerns the gene SFRP1 and hepatocellular carcinoma.